Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Rehabilitation and Therapy
Quantitative Emg Evaluation In Spastic Upper Extremity After Botulinum Toxin Injection-A Preliminary Report, Chiao-Wen Hwang, Ching-Hsiang Lu, Pei-Te Sheu, Ya-Wen Hsu, Kun-Shou Tsai, Ji-Long Wang
Quantitative Emg Evaluation In Spastic Upper Extremity After Botulinum Toxin Injection-A Preliminary Report, Chiao-Wen Hwang, Ching-Hsiang Lu, Pei-Te Sheu, Ya-Wen Hsu, Kun-Shou Tsai, Ji-Long Wang
Rehabilitation Practice and Science
Spasticity of the upper limb muscles is a common complication following stroke. Injection of botulinum toxin can decrease upper limb spasticity. The effects of botulinum toxin treatment are usually evaluated by activities of daily living, range of motion (ROM), or modified Ashworth scale. However, in this study, we evaluated the effect of botulinum toxin injection by quantitative EMG, and investigated the relationship between EMG and conventional evaluation methods.Twenty patients with chronic stroke-related spasticity of the upper limb muscles received botulinum injections. All injections were guided by EMG. Outcome measures included total modified Ashworth scale score on the elbow, wrist, metacarpal …
Long-Term Treatment Of Hemifacial Spasm With Type A Botulinum Toxin, Yu-Ching Llin
Long-Term Treatment Of Hemifacial Spasm With Type A Botulinum Toxin, Yu-Ching Llin
Rehabilitation Practice and Science
Hemifacial spasm is a rare movement disorder. It is characterized by recurrent, involuntary tonic or clonic contraction of the muscles innervated by unilateral facial nerve. It may affect patient’s vision and has great cosmetic or psychological impacts. Oral drugs including anticonvulsants, baclofen and benzodiazepines often have little effect. Surgery has potentially serious complications. After numerous clinical studies, botulinum toxin is now recommended as the primary treatment of choice for most hemifacial spasm cases.The purpose of this study is to retrospectively evaluate the dose, effect and side effects of long-term treatment of hemifacial spasm with type A botulinum toxin. Between November …
Clinical Effects Of Botulinum Toxin On Spasticity Management In Children With Cerebral Palsy, En-Shiuan Wu, Chia-Ling Chen, Alice M.K. Wong, Ching-Kai Wong, Jun-Xiao Chen, Shin-Ming Lo
Clinical Effects Of Botulinum Toxin On Spasticity Management In Children With Cerebral Palsy, En-Shiuan Wu, Chia-Ling Chen, Alice M.K. Wong, Ching-Kai Wong, Jun-Xiao Chen, Shin-Ming Lo
Rehabilitation Practice and Science
Botulinum toxin type A (BTA) has treated spasticity in cerebral palsy (CP) in recent years. This study investigated both the clinical effects and gait improvements of BTA on spasticity management in children with CP.Twenty-nine children with spastic CP (2-10 years old) were recruited into this study. All subjects received complete clinical assessments, video recording and functional assessments before and 1-3 months after BTA treatment. A questionnaire was employed for the evaluation of parents’ subjective satisfaction. Clinical assessments included muscle tone and joint range of motion (ROM) of bilateral lower limbs. ROMs, including dynamic (R1) and static (R2), were measured by …